Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
IM Cannabis Corp. completed a US$225,000 convertible note financing led by an institutional investor for general corporate purposes.
PUBLIC · IMCCJul 01, 2026•about 2 months ago
Amount Raised
$225,000
Round Type
Pre-Seed
HerzliyaOtherManufacturingBiotechnologyFood and BeverageCommunity And LifestyleHealth CareMedicalCannabis
Investors
Institutional Investor
Description
IM Cannabis Corp. announced the closing of a US$225,000 convertible note financing in a private placement. The funds will be used for general corporate purposes. The note includes an interest rate of 8% per annum
Company Information
Company
IM Cannabis
Location
Herzliya, Tel Aviv, Israel
About
IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company's unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally.
Don't miss IM Cannabis's next move
Get an email the moment IM Cannabis raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts26 people are listed at IM Cannabis. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for IM Cannabis's next move